IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,024,971 ▲ 0.53% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL5.15▲ 0.02% USD/MXN16.98▲ 0.13% USD/CLP920.93▲ 0.84% USD/COP3,122▲ 0.90% USD/PEN3.35▲ 0.26% USD/ARS1,514▲ 0.17% USD/UYU40.18▲ 1.55% USD/PYG5,957▲ 0.99% USD/BOB11.50▲ 1.47% USD/DOP58.01▲ 0.33% USD/CRC450.21▲ 2.07% USD/GTQ7.62▲ 2.21% USD/HNL26.82▲ 0.34% USD/NIO36.62▲ 0.79% USD/VES789.35▲ 0.36% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 1.10% EUR/BRL6.00▼ 0.02% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,024,971 ▲ 0.53% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Thursday, August 27, 2026

Brazil Business - Brazil

Paraguay’s former foreign minister says countries were “deceived” by Covax

By · May 4, 2022 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – On May 3, the former Paraguayan Foreign Minister Euclides Acevedo said that his country, along with others, was “deceived” by the Covax mechanism for the distribution of vaccines against covid-19.

In declarations from the Government Palace, Acevedo, who resigned on Friday to enter the electoral race, said he hoped that Paraguay could recover “a high percentage” of the resources it allocated to purchase the vaccines against the virus.

Paraguay was not the only victim,” said the former official about the situation with the mechanism promoted by the World Health Organization and the Vaccine Alliance (GAVI).

The agreement foresaw the delivery of some four million biologicals, of which "a little more than one million" arrived, said the minister at the time.
The agreement foresaw the delivery of some four million biologicals, of which “a little more than one million” arrived, said the minister at the time. (Photo: internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

“Other countries were deceived just like us. It was not a problem between Paraguay and Covax; it was between Covax and many of the countries that also trusted the system,” he added.

The former head of Paraguayan diplomacy regretted that they had committed “the naivety” of having directed their first economic resources to this system and indicated that this “willingness and trust” was not repaid with what the country needed.

According to the former minister, the “great failure of the Covax system” took his country “with its underpants down,” but he highlighted the support of international cooperation to overcome the situation.

Acevedo explained that Paraguay has been working “for quite some time now” on the renegotiation of the agreements signed and hoped that it could obtain “good results”.

The lack of vaccines, medicines, and supplies amid the covid-19 health alert unleashed in March 2021 a series of protests by citizens demanding the resignation of the Paraguayan president, Mario Abdo Benítez, for his handling of the pandemic.

The crisis forced the president to announce changes in his cabinet after the resignation of the then Minister of Health, Julio Mazzoleni.

Regarding the situation with Covax, the Minister of Health, Julio Borba, said last April that Paraguay is seeking to reach an “amicable” agreement to terminate the deal since it does not need a little more than three million vaccines remaining from the contracted lot.

The agreement foresaw the delivery of some four million biologicals, of which “a little more than one million” arrived, said the minister at the time.

With information from EFE

Key Facts

Deep Dive

For the complete picture, read our in-depth guide: Paraguay: Washington's Most Valued Ally in Latin America

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.